Recommended listing of new drug offers hope to those living with metastatic breast cancer
By API User
Breast Cancer Network Australia (BCNA) has welcomed today’s decision to recommend a new targeted treatment for metastatic breast cancer for PBS subsidy. Clinical trials show the new medicine TRUQAP® (capivasertib), in combination with hormone blocking treatment fulvestrant, keeps cancer from growing or spreading for more than twice as long than fulvestrant alone. The … Continued